The biomarker plasma galectin-3 in advanced heart failure and survival with mechanical circulatory support devices

Journal of Heart and Lung Transplantation

Volumn 32, Issue 2, 2013, Pages 221-230

  Erkilet, Gülsüm ^a   Özpeker, Cenk ^a   Böthig, Dietmar ^b   Kramer, Frank ^c   Röfe, Daniela ^a   Bohms, Birte ^a   Morshuis, Michiel ^a   Gummert, Jan ^a   Milting, Hendrik ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Bayer Schering Pharma ^*  (Germany)

Author keywords

biomarker; Galectin 3; mechanical unloading; risk assessment; survival; ventricular assist device

Indexed keywords

GALECTIN 3; MESSENGER RNA;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART MUSCLE; HEART TRANSPLANTATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RISK FACTOR; SURVIVAL; VENTRICULAR ASSIST DEVICE;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; GALECTIN 3; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PREOPERATIVE PERIOD; RISK FACTORS;

EID: 84872855841     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.11.011     Document Type: Article

References (18)

1. M.S. Slaughter, J.G. Rogers, and C.A. Milano Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
2. R.A. de Boer, A.A. Voors, and P. Muntendam Galectin-3: a novel mediator of heart failure development and progression Eur J Heart Fail 11 2009 811 817
3. U.C. Sharma, S. Pokharel, and T.J. van Brakel Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction Circulation 110 2004 3121 3128
4. G.M. Felker, M. Fiuzat, and L.K. Shaw Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION Study Circ Heart Fail 5 2011 72 78
5. D.J. Lok, P. van der Meer, and P.W. de la Porte Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study Clin Res Cardiol 99 2010 323 328
6. R.A. de Boer, D.J. van Veldhuisen, and R.T. Gansevoort The fibrosis marker galectin-3 and outcome in the general population J Intern Med 272 2011 55 64
7. R.R. van Kimmenade, J.L. Januzzi Jr, and P.T. Ellinor Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 2006 1217 1224
8. E.W. Grandin, P. Jarolim, and S.A. Murphy Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22 Clin Chem 2011 58
9. H. Milting, P. Ellinghaus, and M. Seewald Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices J Heart Lung Transplant 27 2008 589 596
10. 2+-dependent ATPase-activity in left ventricular myocardium during mechanical circulatory support J Heart Lung Transplant 22 2003 1209 1216
11. V. Sundblad, D.O. Croci, and G.A. Rabinovich Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues Histol Histopathol 26 2011 247 265
12. T. Ueland, P. Aukrust, and K. Broch Galectin-3 in heart failure: high levels are associated with all-cause mortality Int J Cardiol 150 2011 361 364
13. R.V. Shah, A.A. Chen-Tournoux, and M.H. Picard Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure Eur J Heart Fail 12 2010 826 832
14. R.A. de Boer, D.J. Lok, and T. Jaarsma Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction Ann Med 43 2011 60 68
15. Y. Nishi, H. Sano, and T. Kawashima Role of galectin-3 in human pulmonary fibrosis Allergol Int 56 2007 57 65
16. Y.H. Liu, M. D'Ambrosio, and T.D. Liao N-acetyl-seryl-aspartyl-lysyl- proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin Am J Physiol Heart Circ Physiol 296 2009 H404 H412
17. M. Nachtigal, A. Ghaffar, and E.P. Mayer Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice Am J Pathol 172 2008 247 255
18. W.L. Holman, R.L. Kormos, and D.C. Naftel Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study J Heart Lung Transplant 28 2009 44 50